Home > Insider Trading > Filing (0001156039-24-000029)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1156039	Elevance Health Inc.	ELV	Hospital & Medical Service Plans (6324)	352145715

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1608538	D Peter Haytaian	220 Virginia Avenue Indianapolis IN 46204	Evp & Pres Carelon & Carelonrx	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-03-01	4,314	$499.11	13,425	No	4	F	Direct
Common Stock	Acquisiton	2024-03-01	2,405	$0.00	15,830	No	4	A	Direct
Common Stock	Acquisiton	2024-03-01	9,152	$0.00	24,982	No	4	A	Direct
Common Stock	Acquisiton	2024-03-04	15,000	$166.97	39,982	No	4	M	Direct
Common Stock	Disposition	2024-03-04	4,206	$500.18	35,776	No	4	S	Direct
Common Stock	Disposition	2024-03-04	1,889	$500.18	33,887	No	4	S	Direct
Common Stock	Disposition	2024-03-04	15,000	$500.18	18,887	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2024-03-01	9,280	$0.00	9,280	$499.11
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2024-03-04	15,000	$0.00	15,000	$166.97

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,280		2034-03-01	No	4	A	Direct
4,908		2027-03-01	No	4	M	Direct

Footnotes

PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Represents restricted share units. Restrictions lapse as follows:801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027.
Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023.
This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected.
The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.
The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on 9/1/2017, which is the six-month anniversary of the date on which the option was granted.